Invention Grant
US07659299B2 Compounds inhibiting the binding of sap for treating osteoarthritis
有权
抑制汁液结合治疗骨关节炎的化合物
- Patent Title: Compounds inhibiting the binding of sap for treating osteoarthritis
- Patent Title (中): 抑制汁液结合治疗骨关节炎的化合物
-
Application No.: US10559814Application Date: 2004-06-10
-
Publication No.: US07659299B2Publication Date: 2010-02-09
- Inventor: Mark B. Pepys , Philip Nigel Hawkins
- Applicant: Mark B. Pepys , Philip Nigel Hawkins
- Applicant Address: GB London
- Assignee: Pentraxin Therapeutics Limited
- Current Assignee: Pentraxin Therapeutics Limited
- Current Assignee Address: GB London
- Agency: Frommer Lawrence & Haug LLP
- Agent Thomas J. Kowalski; Deborah L. Lu
- Priority: GB0313386.5 20030610
- International Application: PCT/GB2004/002445 WO 20040610
- International Announcement: WO2004/108131 WO 20041216
- Main IPC: A61K31/40
- IPC: A61K31/40 ; C07D207/16
Abstract:
Use of an agent capable of inhibiting SAP ligand binding activity or depleting SAP from the plasma of a subject for the production of a medicament for treatment or prevention of osteoarthritis in the subject.
Public/Granted literature
- US20080249003A1 Compounds Inhibiting the Binding of Sap for Treating Osteoarthritis Public/Granted day:2008-10-09
Information query
